Efficacy and safety of telitacicept in patients with systemic lupus erythematosus: a multicentre, retrospective, real-world study

OBJECTIVE: To examine the efficacy and safety of telitacicept in the treatment of patients with SLE in everyday clinical practice. METHODS: Seventy-two patients with active SLE who received telitacicept for more than 24 weeks at multiple centres in China between 2019 and 2022 were retrospectively id...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Hui-Zhi, Li, Yu-jing, Wang, Xin, Li, Zhijun, Ma, Bin, Niu, Lin, Wang, Peng, Pan, Hai-feng, Li, Si-dong, Bao, Wei, Wang, Guosheng, Li, Xiao-mei, Chen, Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical Trials and Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679987/
https://www.ncbi.nlm.nih.gov/pubmed/38007228
http://dx.doi.org/10.1136/lupus-2023-001074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679987/
https://www.ncbi.nlm.nih.gov/pubmed/38007228
http://dx.doi.org/10.1136/lupus-2023-001074

Ejemplares similares